An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
一项关于食管鳞状细胞癌新辅助放化疗与根据需要进行挽救性手术的根治性放化疗的国际随机试验 - NEEDS 试验
基本信息
- 批准号:469430
- 负责人:
- 金额:$ 132.08万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-09-01 至 2030-03-01
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Esophageal cancer is the 6th leading cause of cancer death worldwide. Curative treatment for esophageal squamous cell carcinoma (ESCC), representing 90% of cases globally, is controversial. Candidates for surgery are preferably treated with chemoradiother
食管癌是全球第六大癌症死亡原因。食管鳞状细胞癌(ESCC)占全球病例的90%,其治愈性治疗存在争议。手术候选者最好用放化疗治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lukovic Jelena其他文献
Lukovic Jelena的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lukovic Jelena', 18)}}的其他基金
Prize 202209PJT - Early Career Award in Cancer: An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
奖 202209PJT - 癌症早期职业奖:食管鳞状细胞癌新辅助放化疗与根治性放化疗(根据需要进行挽救手术)的国际随机试验 - NEEDS 试验
- 批准号:
477684 - 财政年份:2022
- 资助金额:
$ 132.08万 - 项目类别:
Operating Grants
相似海外基金
Individualising Radiotherapy Through Mechanistic Models
通过机制模型实现个体化放射治疗
- 批准号:
MR/Y019792/1 - 财政年份:2024
- 资助金额:
$ 132.08万 - 项目类别:
Fellowship
Tongue-out Radiotherapy:毒性低減のための新アプローチ
吐舌放射治疗:减少毒性的新方法
- 批准号:
24K10860 - 财政年份:2024
- 资助金额:
$ 132.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the mechanistic basis of photon FLASH radiotherapy in tumours & normal tissues
研究光子闪光放射治疗肿瘤的机制基础
- 批准号:
MR/Y012097/1 - 财政年份:2024
- 资助金额:
$ 132.08万 - 项目类别:
Research Grant
Quantifying the personalised impact of physical and biological uncertainties in customised radiotherapy treatment planning
量化定制放射治疗计划中物理和生物不确定性的个性化影响
- 批准号:
2907229 - 财政年份:2024
- 资助金额:
$ 132.08万 - 项目类别:
Studentship
Measurement and analysis of radiotherapy small field dosimetry data to support the development of a simulation training product for clinical Radiotherapy Physicists.
放射治疗小场剂量测定数据的测量和分析,以支持临床放射治疗物理学家模拟培训产品的开发。
- 批准号:
10089179 - 财政年份:2024
- 资助金额:
$ 132.08万 - 项目类别:
Collaborative R&D
Application of IL-1RA to the sensitizing and mucositis-preventive effects of oral cancer radiotherapy.
IL-1RA在口腔癌放疗增敏和预防粘膜炎中的应用。
- 批准号:
23K08931 - 财政年份:2023
- 资助金额:
$ 132.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Is radiotherapy gentle for elderly cancer patients? Can radiotherapy be gentle to elderly cancer patients?
放疗对老年癌症患者温和吗?
- 批准号:
23K07056 - 财政年份:2023
- 资助金额:
$ 132.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of real-time dosimetry system for radiotherapy using deep learning
利用深度学习开发放射治疗实时剂量测定系统
- 批准号:
23K07109 - 财政年份:2023
- 资助金额:
$ 132.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 132.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages
通过肿瘤支持巨噬细胞的治疗诊断靶向改善神经胶质瘤放射治疗
- 批准号:
10629547 - 财政年份:2023
- 资助金额:
$ 132.08万 - 项目类别: